Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Aurinia Pharmaceuticals Inc AUPH

Healthcare Biotechnology
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing... see more

Current News (NDAQ:AUPH)

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

Business Wire November 4, 2025

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025

Business Wire November 3, 2025

Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025

Business Wire October 15, 2025

Aurinia Responds to Now Retracted LinkedIn Post

Business Wire September 29, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025

Business Wire July 31, 2025

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025

Business Wire July 22, 2025

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

Business Wire June 30, 2025

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

Business Wire June 29, 2025

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

Business Wire May 22, 2025
View More News ››

Opinion & Analysis (NDAQ:AUPH)

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

Streetwise Reports December 7, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AUPH)

Aurinia (NASDAQ:AUPH) Soars on Strong Q1 2024 Results and Pr

http://beyondspx.com/2024/07/31/aurinia-nasdaqauph-soars-on-strong-q1-2024-results-and-promising-outlook/
MikeTester - August 2, 2024

Insider Buying

Caught this at the end of today's trading: https://https://newsfilter.io/a/f3900452b2cccee8cead342dda3d2a24m---statement-of...
Apostata - December 15, 2021

More good results

Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults...
ZoranSto - December 9, 2021

RE:RE:RE:WTH ? Happened today ?

New suitor reported again. Short term price changes are just games with the shorts, they have beat this thing hard and won't let it...
jboom70 - December 4, 2021

RE:RE:WTH ? Happened today ?

I also see there was a shite load of insider sales in November , That is not a good sign.
TheRainman - November 22, 2021

RE:WTH ? Happened today ?

Aurinia announced a possible large financing Friday after the close.  Obviously, if they are doing a financing, they aren't...
TimeScape - November 22, 2021
View more Bullboard ››

Spod Lithium Corp.

Spod Lithium Corp.

Spod Lithium Corp., a mineral exploration company, engages in the acquisition and development of mineral properties in Canada ...
View More »